AUA 2018 Bladder Cancer - Results from #20

Viewing 21-40 of 51 articles

AUA 2018: Treatment for MIBC for Cis-Platinum Ineligible Patients: Immediate Cystectomy

AUA 2018: Treatment for MIBC for Cis-Platinum Ineligible Patients: Other Systemic Options and Trials

AUA 2018: High Risk BCG Recurrent/Refractory Disease: Immediate Cystectomy

AUA 2018: Phase 3 Study of Vicinium in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: Initial Results

AUA 2018: Results of CALIBER: A Phase II Randomized Feasibility Trial of Chemoablation vs Surgical Management in Low Risk Non-Muscle Invasive Bladder Cancer

AUA 2018: Non-Surgical Management of Low Grade Upper Tract Urothelial Cancer: an Interim Analysis of the International Multicenter OLYMPUS Trial

AUA 2018: CG0070, an Oncolytic Adenovirus, for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: 12 Month Interim Results from a Multicenter Phase II Trial

AUA 2018: High Risk BCG Recurrent/Refractory Disease: Secondary Intravesical Therapy

AUA 2018: Adherence to Bladder Cancer Guidelines and Issues with Implementation

AUA 2018: Three Articles Last Year that Changed Practice: Bladder Cancer

AUA 2018: Where and How Does Cystoscopy Fall Short? Initial Results of a Prospective Cohort Study Evaluating Reliability of Endoscopic Evaluation in Predicting pT0 Disease at the Time of Radical Cystectomy

AUA 2018: Automated and Dynamic Classification of Bladder Cancer using Deep Learning on Real-Time Confocal Laser Endomicroscopy Images

AUA 2018: Translational Research to Potentiate Immunotherapy in Urothelial Cancer

AUA 2018: Refining Immunotherapy Combinations and Sequencing in Bladder Cancer

AUA 2018: Overview of Immunotherapy in GU Cancers

AUA 2018: Journal of Urology: Top Papers in Bladder and Renal Cancer

AUA 2018: Results of POUT - Phase III Randomized Trial of Peri-Operative Chemotherapy vs. Surveillance in Upper Tract Urothelial Cancer

AUA 2018: Racial Disparities in Quality of Care and Overall Survival among Muscle-Invasive Bladder Cancer Patients treated with Radical Cystectomy

AUA 2018: Neoadjuvant Pembrolizumab Before Radical Cystectomy for Muscle-Invasive Bladder Cancer: Interim Results from PURE-01

AUA 2018: Development of a Predictive Nomogram to Predict Overall Survival Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma

1
2
3